FI3664628T3 - Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia - Google Patents
Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia Download PDFInfo
- Publication number
- FI3664628T3 FI3664628T3 FIEP18844969.8T FI18844969T FI3664628T3 FI 3664628 T3 FI3664628 T3 FI 3664628T3 FI 18844969 T FI18844969 T FI 18844969T FI 3664628 T3 FI3664628 T3 FI 3664628T3
- Authority
- FI
- Finland
- Prior art keywords
- omega
- emulsion
- emulsion composition
- fatty acids
- mct
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 44
- 239000000839 emulsion Substances 0.000 title claims 37
- 235000020660 omega-3 fatty acid Nutrition 0.000 title claims 19
- 229940012843 omega-3 fatty acid Drugs 0.000 title claims 19
- 235000021323 fish oil Nutrition 0.000 title claims 16
- 239000006014 omega-3 oil Substances 0.000 title claims 13
- 229940057917 medium chain triglycerides Drugs 0.000 claims 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 6
- 239000003921 oil Substances 0.000 claims 5
- 235000019198 oils Nutrition 0.000 claims 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 208000012347 Parenteral nutrition associated liver disease Diseases 0.000 claims 4
- 206010033645 Pancreatitis Diseases 0.000 claims 3
- 239000000654 additive Substances 0.000 claims 3
- 229940087168 alpha tocopherol Drugs 0.000 claims 3
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims 3
- 229940033080 omega-6 fatty acid Drugs 0.000 claims 3
- 229960000984 tocofersolan Drugs 0.000 claims 3
- 239000002076 α-tocopherol Substances 0.000 claims 3
- 235000004835 α-tocopherol Nutrition 0.000 claims 3
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010016260 Fatty acid deficiency Diseases 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000037112 Intestinal Failure Diseases 0.000 claims 2
- 208000033147 Parenteral nutrition-associated cholestasis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims 2
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- 229940068065 phytosterols Drugs 0.000 claims 2
- 235000019165 vitamin E Nutrition 0.000 claims 2
- 239000011709 vitamin E Substances 0.000 claims 2
- 229940046009 vitamin E Drugs 0.000 claims 2
- 208000003918 Acute Kidney Tubular Necrosis Diseases 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 206010006803 Burns third degree Diseases 0.000 claims 1
- 206010008609 Cholangitis sclerosing Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010317 Congenital absence of bile ducts Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010021263 IgA nephropathy Diseases 0.000 claims 1
- 206010033647 Pancreatitis acute Diseases 0.000 claims 1
- 206010038540 Renal tubular necrosis Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 208000005279 Status Asthmaticus Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 206010000891 acute myocardial infarction Diseases 0.000 claims 1
- 201000003229 acute pancreatitis Diseases 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 201000005271 biliary atresia Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 1
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000004968 inflammatory condition Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 1
- 239000002960 lipid emulsion Substances 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000035764 nutrition Effects 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 235000016236 parenteral nutrition Nutrition 0.000 claims 1
- 201000000742 primary sclerosing cholangitis Diseases 0.000 claims 1
- 208000010157 sclerosing cholangitis Diseases 0.000 claims 1
- 208000007056 sickle cell anemia Diseases 0.000 claims 1
- 208000005809 status epilepticus Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762543437P | 2017-08-10 | 2017-08-10 | |
| PCT/US2018/046206 WO2019032959A1 (en) | 2017-08-10 | 2018-08-10 | METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND / OR OMEGA-3 FATTY ACIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3664628T3 true FI3664628T3 (fi) | 2025-02-04 |
Family
ID=65271269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18844969.8T FI3664628T3 (fi) | 2017-08-10 | 2018-08-10 | Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11324697B2 (enExample) |
| EP (2) | EP3664628B1 (enExample) |
| JP (1) | JP7370317B2 (enExample) |
| KR (2) | KR102677006B1 (enExample) |
| CN (3) | CN118000419A (enExample) |
| AU (1) | AU2018313260B2 (enExample) |
| CA (1) | CA3070481A1 (enExample) |
| DK (1) | DK3664628T3 (enExample) |
| ES (1) | ES3012510T3 (enExample) |
| FI (1) | FI3664628T3 (enExample) |
| HR (1) | HRP20250125T1 (enExample) |
| PH (1) | PH12020500267A1 (enExample) |
| PL (1) | PL3664628T3 (enExample) |
| PT (1) | PT3664628T (enExample) |
| SG (2) | SG11202000592WA (enExample) |
| WO (1) | WO2019032959A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230113738A1 (en) * | 2020-03-06 | 2023-04-13 | Optimega Llc | Fatty acid compositions for enteral use |
| WO2021243526A1 (zh) * | 2020-06-01 | 2021-12-09 | 苏州大学附属儿童医院 | 新生儿肠外营养相关性肝病特异性标志物lncRNA的应用 |
| US20230241124A1 (en) * | 2020-07-14 | 2023-08-03 | Nutrition Lipid Developments | Isotonic lipid emulsion |
| KR20230010404A (ko) | 2021-07-12 | 2023-01-19 | 에이치케이이노엔 주식회사 | 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제 |
| CN116754711B (zh) * | 2023-08-17 | 2023-11-07 | 蓝星安迪苏南京有限公司 | 饲料用乳化剂的乳化能力评估方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2738253A1 (de) | 1977-08-25 | 1979-03-01 | Dabisch Tipp Ex Tech | Koerper mit reversibel temperaturabhaengiger transparenz |
| DE2749265A1 (de) | 1977-11-03 | 1979-05-10 | Linde Ag | Verfahren zur biologischen reinigung von abwasser |
| US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
| JPS61501558A (ja) * | 1984-01-16 | 1986-07-31 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド | 中および長鎖トリグリセライドの非経口栄養補給 |
| US4752618A (en) | 1984-07-12 | 1988-06-21 | New England Deaconess Hospital | Method of minimizing efects of infection through diet |
| DE3722540A1 (de) | 1987-07-08 | 1989-01-19 | Fresenius Ag | Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung |
| DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
| DE3903056A1 (de) * | 1989-02-02 | 1990-08-09 | Braun Melsungen Ag | Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung |
| SE9101642D0 (sv) | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
| WO1993009772A1 (fr) | 1991-11-14 | 1993-05-27 | Sagami Chemical Research Center | Medicament contre des maladies hepatiques |
| US5728385A (en) | 1993-08-12 | 1998-03-17 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| US5574065A (en) * | 1994-04-21 | 1996-11-12 | Clintec Nutrition Co. | Method and composition for normalizing injury response |
| JP2000501131A (ja) * | 1995-11-24 | 2000-02-02 | ロダース・クロックラーン・ビー・ブイ | 魚油をベースとする組成物 |
| ATE230262T1 (de) * | 1995-11-28 | 2003-01-15 | Braun Melsungen Ag | Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung |
| US20030068385A1 (en) | 2001-03-23 | 2003-04-10 | Moyer Mary Pat | Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy |
| CA2452401C (en) * | 2001-07-02 | 2013-02-26 | Suntory Limited | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
| EP1279400A1 (en) * | 2001-07-25 | 2003-01-29 | Target Hit sa | Modifying the fatty acid composition of cell membranes of organs and tissues |
| FI114894B (fi) | 2002-05-02 | 2005-01-31 | Omecol Finland Oy | Elintarvikekoostumus |
| DE10254584A1 (de) * | 2002-11-22 | 2004-06-09 | HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie | Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker |
| CA2545752C (en) * | 2003-11-12 | 2013-03-26 | Children's Medical Center Corporation | Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
| EP1723096A4 (en) * | 2004-03-04 | 2008-03-05 | Htl High Tech Lipids Ltd | TRIGLYCERIDES STRUCTURES AND EMULSIONS CONTAINING THESE TRIGLYCERIDES |
| CA2573054C (en) * | 2004-07-02 | 2012-10-09 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
| WO2008036353A2 (en) | 2006-09-19 | 2008-03-27 | The Trustees Of Columbia University In The City Of New York | Omega-3 diglyceride emulsions |
| CN1965806A (zh) * | 2006-11-09 | 2007-05-23 | 华瑞制药有限公司 | 一种含大豆油、中链甘油三酯、橄榄油和鱼油的脂肪乳注射液及其制造方法 |
| US7666828B2 (en) * | 2008-01-22 | 2010-02-23 | Stepan Company | Sulfonated estolides and other derivatives of fatty acids, methods of making them, and compositions and processes employing them |
| US8241672B2 (en) | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| US9034389B2 (en) * | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| US20120277316A1 (en) | 2010-01-19 | 2012-11-01 | University of Tennesse Research Foundation a university | Methods and compositions for treating and preventing parenteral nutrition associated liver disease |
| WO2011133841A2 (en) * | 2010-04-23 | 2011-10-27 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Intravenous omega-3 fatty acid compositions & method of use |
| US10052352B2 (en) * | 2011-06-15 | 2018-08-21 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| JP5864735B2 (ja) | 2011-06-15 | 2016-02-17 | ステイブル ソリューションズ エルエルシーＳｔａｂｌｅ Ｓｏｌｕｔｉｏｎｓ Ｌｌｃ | 非経口オキアミ油の治療用途 |
| WO2013063067A1 (en) | 2011-10-24 | 2013-05-02 | Stable Solutions Llc | Enriched injectable emulsion containing selected fatty acid triglycerides |
| WO2013127727A1 (en) * | 2012-02-29 | 2013-09-06 | B. Braun Melsungen Ag | Hormone containing emulsion comprising krill phospholipids |
| WO2016040570A2 (en) * | 2014-09-12 | 2016-03-17 | Children's Medical Center Corporation | Dietary emulsion formulations and methods for using the same |
| JP6814148B2 (ja) | 2015-03-31 | 2021-01-13 | フレゼニウス カービ ドイチュラント ゲーエムベーハー | 非経口投与用のエマルション |
-
2018
- 2018-08-10 CN CN202311628291.4A patent/CN118000419A/zh active Pending
- 2018-08-10 WO PCT/US2018/046206 patent/WO2019032959A1/en not_active Ceased
- 2018-08-10 CN CN202311633119.8A patent/CN117918525A/zh active Pending
- 2018-08-10 HR HRP20250125TT patent/HRP20250125T1/hr unknown
- 2018-08-10 EP EP18844969.8A patent/EP3664628B1/en active Active
- 2018-08-10 AU AU2018313260A patent/AU2018313260B2/en active Active
- 2018-08-10 SG SG11202000592WA patent/SG11202000592WA/en unknown
- 2018-08-10 CA CA3070481A patent/CA3070481A1/en active Pending
- 2018-08-10 KR KR1020207003868A patent/KR102677006B1/ko active Active
- 2018-08-10 SG SG10202108769WA patent/SG10202108769WA/en unknown
- 2018-08-10 CN CN201880058296.9A patent/CN111093399A/zh active Pending
- 2018-08-10 PT PT188449698T patent/PT3664628T/pt unknown
- 2018-08-10 EP EP24198450.9A patent/EP4450090A3/en active Pending
- 2018-08-10 PL PL18844969.8T patent/PL3664628T3/pl unknown
- 2018-08-10 KR KR1020247020091A patent/KR20240101693A/ko active Pending
- 2018-08-10 JP JP2020507088A patent/JP7370317B2/ja active Active
- 2018-08-10 ES ES18844969T patent/ES3012510T3/es active Active
- 2018-08-10 FI FIEP18844969.8T patent/FI3664628T3/fi active
- 2018-08-10 US US16/634,194 patent/US11324697B2/en active Active
- 2018-08-10 DK DK18844969.8T patent/DK3664628T3/da active
-
2020
- 2020-02-05 PH PH12020500267A patent/PH12020500267A1/en unknown
-
2022
- 2022-04-07 US US17/715,612 patent/US20220226238A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7370317B2 (ja) | 2023-10-27 |
| ES3012510T3 (en) | 2025-04-09 |
| CN118000419A (zh) | 2024-05-10 |
| RU2020109759A3 (enExample) | 2021-11-15 |
| CN111093399A (zh) | 2020-05-01 |
| AU2018313260B2 (en) | 2024-06-20 |
| HRP20250125T1 (hr) | 2025-03-28 |
| KR20200038472A (ko) | 2020-04-13 |
| EP4450090A3 (en) | 2025-01-29 |
| PT3664628T (pt) | 2024-12-31 |
| US20200345638A1 (en) | 2020-11-05 |
| PH12020500267A1 (en) | 2020-09-21 |
| PL3664628T3 (pl) | 2025-04-07 |
| DK3664628T3 (da) | 2025-01-13 |
| RU2020109759A (ru) | 2021-09-10 |
| US11324697B2 (en) | 2022-05-10 |
| SG10202108769WA (en) | 2021-09-29 |
| WO2019032959A1 (en) | 2019-02-14 |
| EP3664628A4 (en) | 2021-04-14 |
| EP4450090A2 (en) | 2024-10-23 |
| AU2018313260A1 (en) | 2020-01-16 |
| JP2020530464A (ja) | 2020-10-22 |
| US20220226238A1 (en) | 2022-07-21 |
| KR20240101693A (ko) | 2024-07-02 |
| KR102677006B1 (ko) | 2024-06-25 |
| SG11202000592WA (en) | 2020-02-27 |
| EP3664628B1 (en) | 2024-12-11 |
| BR112020002638A2 (pt) | 2020-08-18 |
| CA3070481A1 (en) | 2019-02-14 |
| EP3664628A1 (en) | 2020-06-17 |
| CN117918525A (zh) | 2024-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3664628T3 (fi) | Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia | |
| RU2014138996A (ru) | Гормонсодержащая эмульсия | |
| ES2324526T3 (es) | Emulsiones isotonicas de lipidos. | |
| ES2841344T3 (es) | Composición autoemulsionante de ácidos grasos omega-3 | |
| JP5864735B2 (ja) | 非経口オキアミ油の治療用途 | |
| RU2011141102A (ru) | Обогащенные омега-3 рыбные парентеральные питательные эмульсии типа масло в воде | |
| JP2015527386A5 (enExample) | ||
| US20070122452A1 (en) | Fat composition | |
| JP2014517028A5 (enExample) | ||
| RU2013145701A (ru) | Способ лечения нейротравмы | |
| ES2976095T3 (es) | Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas | |
| JP2020530464A5 (enExample) | ||
| BR112020000600A2 (pt) | composição nutricional enteral, uso de uma composição nutricional enteral, e método para tratamento de traumatismo cranioencefálico | |
| JPWO2012067224A1 (ja) | 角膜上皮障害及び／又は結膜上皮障害の治療又は予防剤 | |
| KR19980701452A (ko) | 피부염 치료제(Remedy for Dermatitis) | |
| JP2020182497A5 (enExample) | ||
| US10052352B2 (en) | Therapeutic application of parenteral krill oil | |
| JP6949670B2 (ja) | 難溶性物質を含有する経口摂取用組成物、難溶性物質の消化管吸収性の向上方法及び難溶性物質を含有する水中油型乳化物の胃内での乳化安定化方法 | |
| CN104739763A (zh) | 一种具有抗炎和抗血栓形成作用的静脉注射用脂肪乳剂及其制备方法和用途 | |
| JPH04244023A (ja) | ω６系不飽和脂肪酸含有薬剤 | |
| CA2943000A1 (en) | Homogeneous formulation comprising omega-3 polyunsaturated fatty acid and resveratrol for oral administration | |
| ES2250397T3 (es) | Preparado de combinacion de acidos grasos omega-3 y acidos linoleicos conjugados para el tratamiento de cuadros clinicos de caracter inmunologico. | |
| Sprygin | Assessment of the hepatoprotective effect of lipid complex from marine red algae Ahnfeltia tobuchiensis against CCl4 induced hepatotoxicity in mice | |
| CN118678891A (zh) | 与脂肪酸缺乏的治疗和预防有关的方法和组合物 | |
| JPWO2023107527A5 (enExample) |